Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2013-08, Vol.32 (31), p.3616
Hauptverfasser: Calao, M, Sekyere, E.O, Cui, H.J, Cheung, B.B, Thomas, W.D, Keating, J, Chen, J.B, Raif, A, Jankowski, K, Davies, N.P, Bekkum, M.V, Chen, B, Tan, O, Ellis, T, Norris, M.D, Haber, M, Kim, E.S, Shohet, J.M, Trahair, T.N, Liu, T, Wainwright, B.J, Ding, H.F, Marshall, G.M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 31
container_start_page 3616
container_title Oncogene
container_volume 32
creator Calao, M
Sekyere, E.O
Cui, H.J
Cheung, B.B
Thomas, W.D
Keating, J
Chen, J.B
Raif, A
Jankowski, K
Davies, N.P
Bekkum, M.V
Chen, B
Tan, O
Ellis, T
Norris, M.D
Haber, M
Kim, E.S
Shohet, J.M
Trahair, T.N
Liu, T
Wainwright, B.J
Ding, H.F
Marshall, G.M
description Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-[MYCN.sup.+/+] transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation. Oncogene (2013) 32, 3616-3626; doi:10.1038/onc.2012.368; published online 20 August 2012 Keywords: Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis
doi_str_mv 10.1038/onc.2012.368
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A341458331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A341458331</galeid><sourcerecordid>A341458331</sourcerecordid><originalsourceid>FETCH-LOGICAL-g671-2ac26e31dc6cbf74c602b38a1d2f5ec24467e5e91b8a20b2e91762b496c5c2e23</originalsourceid><addsrcrecordid>eNptjM9KAzEQxnNQsFZvPkDA89ZkspvdPdb6Fwpeei_Z6aREdpOSpELfwkc2oKAHGZhv5pvffIzdSLGQQnV3weMChISF0t0Zm4m-EVUPCi7YZUrvQoi2FzBjnw8uEmZO1hZJPFh-P7mRB88PjeKHGDI5z1M2gxtdPnHnDWb3YTIV2GP4JSKlxEs7BJ_KsXg0DfEUvBk5Go8USxzhMaYQOdI4Jm4yz8eprM677Ex2wV-xc2vGRNc_Omebp8fN6qVavz2_rpbraq9bWYFB0KTkDjUOtq1RCxhUZ-QObEMIda1baqiXQ2dADFCmVsNQ9xobBAI1Z7ffsXsz0tZ5G3I0OLmE26WqZd10SslCLf6hSu1ochg8WVf8Pw9f7Sx2-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation</title><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Calao, M ; Sekyere, E.O ; Cui, H.J ; Cheung, B.B ; Thomas, W.D ; Keating, J ; Chen, J.B ; Raif, A ; Jankowski, K ; Davies, N.P ; Bekkum, M.V ; Chen, B ; Tan, O ; Ellis, T ; Norris, M.D ; Haber, M ; Kim, E.S ; Shohet, J.M ; Trahair, T.N ; Liu, T ; Wainwright, B.J ; Ding, H.F ; Marshall, G.M</creator><creatorcontrib>Calao, M ; Sekyere, E.O ; Cui, H.J ; Cheung, B.B ; Thomas, W.D ; Keating, J ; Chen, J.B ; Raif, A ; Jankowski, K ; Davies, N.P ; Bekkum, M.V ; Chen, B ; Tan, O ; Ellis, T ; Norris, M.D ; Haber, M ; Kim, E.S ; Shohet, J.M ; Trahair, T.N ; Liu, T ; Wainwright, B.J ; Ding, H.F ; Marshall, G.M</creatorcontrib><description>Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-[MYCN.sup.+/+] transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation. Oncogene (2013) 32, 3616-3626; doi:10.1038/onc.2012.368; published online 20 August 2012 Keywords: Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis</description><identifier>ISSN: 0950-9232</identifier><identifier>DOI: 10.1038/onc.2012.368</identifier><language>eng</language><publisher>Nature Publishing Group</publisher><subject>Analysis ; Carcinogenesis ; Development and progression ; Health aspects ; Neuroblastoma ; Oncogenes ; Physiological aspects ; Tumor proteins ; Tumor suppressor genes</subject><ispartof>Oncogene, 2013-08, Vol.32 (31), p.3616</ispartof><rights>COPYRIGHT 2013 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Calao, M</creatorcontrib><creatorcontrib>Sekyere, E.O</creatorcontrib><creatorcontrib>Cui, H.J</creatorcontrib><creatorcontrib>Cheung, B.B</creatorcontrib><creatorcontrib>Thomas, W.D</creatorcontrib><creatorcontrib>Keating, J</creatorcontrib><creatorcontrib>Chen, J.B</creatorcontrib><creatorcontrib>Raif, A</creatorcontrib><creatorcontrib>Jankowski, K</creatorcontrib><creatorcontrib>Davies, N.P</creatorcontrib><creatorcontrib>Bekkum, M.V</creatorcontrib><creatorcontrib>Chen, B</creatorcontrib><creatorcontrib>Tan, O</creatorcontrib><creatorcontrib>Ellis, T</creatorcontrib><creatorcontrib>Norris, M.D</creatorcontrib><creatorcontrib>Haber, M</creatorcontrib><creatorcontrib>Kim, E.S</creatorcontrib><creatorcontrib>Shohet, J.M</creatorcontrib><creatorcontrib>Trahair, T.N</creatorcontrib><creatorcontrib>Liu, T</creatorcontrib><creatorcontrib>Wainwright, B.J</creatorcontrib><creatorcontrib>Ding, H.F</creatorcontrib><creatorcontrib>Marshall, G.M</creatorcontrib><title>Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation</title><title>Oncogene</title><description>Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-[MYCN.sup.+/+] transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation. Oncogene (2013) 32, 3616-3626; doi:10.1038/onc.2012.368; published online 20 August 2012 Keywords: Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis</description><subject>Analysis</subject><subject>Carcinogenesis</subject><subject>Development and progression</subject><subject>Health aspects</subject><subject>Neuroblastoma</subject><subject>Oncogenes</subject><subject>Physiological aspects</subject><subject>Tumor proteins</subject><subject>Tumor suppressor genes</subject><issn>0950-9232</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjM9KAzEQxnNQsFZvPkDA89ZkspvdPdb6Fwpeei_Z6aREdpOSpELfwkc2oKAHGZhv5pvffIzdSLGQQnV3weMChISF0t0Zm4m-EVUPCi7YZUrvQoi2FzBjnw8uEmZO1hZJPFh-P7mRB88PjeKHGDI5z1M2gxtdPnHnDWb3YTIV2GP4JSKlxEs7BJ_KsXg0DfEUvBk5Go8USxzhMaYQOdI4Jm4yz8eprM677Ex2wV-xc2vGRNc_Omebp8fN6qVavz2_rpbraq9bWYFB0KTkDjUOtq1RCxhUZ-QObEMIda1baqiXQ2dADFCmVsNQ9xobBAI1Z7ffsXsz0tZ5G3I0OLmE26WqZd10SslCLf6hSu1ochg8WVf8Pw9f7Sx2-w</recordid><startdate>20130801</startdate><enddate>20130801</enddate><creator>Calao, M</creator><creator>Sekyere, E.O</creator><creator>Cui, H.J</creator><creator>Cheung, B.B</creator><creator>Thomas, W.D</creator><creator>Keating, J</creator><creator>Chen, J.B</creator><creator>Raif, A</creator><creator>Jankowski, K</creator><creator>Davies, N.P</creator><creator>Bekkum, M.V</creator><creator>Chen, B</creator><creator>Tan, O</creator><creator>Ellis, T</creator><creator>Norris, M.D</creator><creator>Haber, M</creator><creator>Kim, E.S</creator><creator>Shohet, J.M</creator><creator>Trahair, T.N</creator><creator>Liu, T</creator><creator>Wainwright, B.J</creator><creator>Ding, H.F</creator><creator>Marshall, G.M</creator><general>Nature Publishing Group</general><scope/></search><sort><creationdate>20130801</creationdate><title>Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation</title><author>Calao, M ; Sekyere, E.O ; Cui, H.J ; Cheung, B.B ; Thomas, W.D ; Keating, J ; Chen, J.B ; Raif, A ; Jankowski, K ; Davies, N.P ; Bekkum, M.V ; Chen, B ; Tan, O ; Ellis, T ; Norris, M.D ; Haber, M ; Kim, E.S ; Shohet, J.M ; Trahair, T.N ; Liu, T ; Wainwright, B.J ; Ding, H.F ; Marshall, G.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g671-2ac26e31dc6cbf74c602b38a1d2f5ec24467e5e91b8a20b2e91762b496c5c2e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analysis</topic><topic>Carcinogenesis</topic><topic>Development and progression</topic><topic>Health aspects</topic><topic>Neuroblastoma</topic><topic>Oncogenes</topic><topic>Physiological aspects</topic><topic>Tumor proteins</topic><topic>Tumor suppressor genes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Calao, M</creatorcontrib><creatorcontrib>Sekyere, E.O</creatorcontrib><creatorcontrib>Cui, H.J</creatorcontrib><creatorcontrib>Cheung, B.B</creatorcontrib><creatorcontrib>Thomas, W.D</creatorcontrib><creatorcontrib>Keating, J</creatorcontrib><creatorcontrib>Chen, J.B</creatorcontrib><creatorcontrib>Raif, A</creatorcontrib><creatorcontrib>Jankowski, K</creatorcontrib><creatorcontrib>Davies, N.P</creatorcontrib><creatorcontrib>Bekkum, M.V</creatorcontrib><creatorcontrib>Chen, B</creatorcontrib><creatorcontrib>Tan, O</creatorcontrib><creatorcontrib>Ellis, T</creatorcontrib><creatorcontrib>Norris, M.D</creatorcontrib><creatorcontrib>Haber, M</creatorcontrib><creatorcontrib>Kim, E.S</creatorcontrib><creatorcontrib>Shohet, J.M</creatorcontrib><creatorcontrib>Trahair, T.N</creatorcontrib><creatorcontrib>Liu, T</creatorcontrib><creatorcontrib>Wainwright, B.J</creatorcontrib><creatorcontrib>Ding, H.F</creatorcontrib><creatorcontrib>Marshall, G.M</creatorcontrib><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Calao, M</au><au>Sekyere, E.O</au><au>Cui, H.J</au><au>Cheung, B.B</au><au>Thomas, W.D</au><au>Keating, J</au><au>Chen, J.B</au><au>Raif, A</au><au>Jankowski, K</au><au>Davies, N.P</au><au>Bekkum, M.V</au><au>Chen, B</au><au>Tan, O</au><au>Ellis, T</au><au>Norris, M.D</au><au>Haber, M</au><au>Kim, E.S</au><au>Shohet, J.M</au><au>Trahair, T.N</au><au>Liu, T</au><au>Wainwright, B.J</au><au>Ding, H.F</au><au>Marshall, G.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation</atitle><jtitle>Oncogene</jtitle><date>2013-08-01</date><risdate>2013</risdate><volume>32</volume><issue>31</issue><spage>3616</spage><pages>3616-</pages><issn>0950-9232</issn><abstract>Embryonal cancer can arise from postnatally persistent embryonal remnant or rest cells, which are uniquely characterized by the absence of p53 mutations. Perinatal overexpression of the MycN oncoprotein in embryonal cancer precursor cells causes postnatal rests, and later tumor formation through unknown mechanisms. However, overexpression of Myc in adult tissues normally activates apoptosis and/or senescence signals as an organismal defense mechanism against cancer. Here, we show that perinatal neuroblastoma precursor cells exhibited a transiently diminished p53 response to MycN oncoprotein stress and resistance to trophic factor withdrawal, compared with their adult counterpart cells from the TH-[MYCN.sup.+/+] transgenic mouse model of neuroblastoma. The adult stem cell maintenance factor and Polycomb group protein, Bmi1 (B-cell-specific Moloney murine leukemia virus integration site), had a critical role at neuroblastoma initiation in the model, by repressing p53 responses in precursor cells. We further show in neuroblastoma tumor cells that Bmi1 could directly bind p53 in a complex with other Polycomb complex proteins, Ring1A or Ring1B, leading to increased p53 ubiquitination and degradation. Repressed p53 signal responses were also seen in precursor cells for other embryonal cancer types, medulloblastoma and acute lymphoblastic leukemia. Collectively, these date indicate a general mechanism for p53 inactivation in some embryonal cell types and consequent susceptibility to MycN oncogenesis at the point of embryonal tumor initiation. Oncogene (2013) 32, 3616-3626; doi:10.1038/onc.2012.368; published online 20 August 2012 Keywords: Bmi1; p53; MYCN; neuroblastoma; medulloblastoma; apoptosis</abstract><pub>Nature Publishing Group</pub><doi>10.1038/onc.2012.368</doi></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2013-08, Vol.32 (31), p.3616
issn 0950-9232
language eng
recordid cdi_gale_infotracmisc_A341458331
source Nature; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects Analysis
Carcinogenesis
Development and progression
Health aspects
Neuroblastoma
Oncogenes
Physiological aspects
Tumor proteins
Tumor suppressor genes
title Direct effects of Bmil on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A52%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20effects%20of%20Bmil%20on%20p53%20protein%20stability%20inactivates%20oncoprotein%20stress%20responses%20in%20embryonal%20cancer%20precursor%20cells%20at%20tumor%20initiation&rft.jtitle=Oncogene&rft.au=Calao,%20M&rft.date=2013-08-01&rft.volume=32&rft.issue=31&rft.spage=3616&rft.pages=3616-&rft.issn=0950-9232&rft_id=info:doi/10.1038/onc.2012.368&rft_dat=%3Cgale%3EA341458331%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A341458331&rfr_iscdi=true